Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1985 Feb;19(2):249–254. doi: 10.1111/j.1365-2125.1985.tb02638.x

Lack of effect of tenoxicam on glibornuride kinetics and response.

K Stoeckel, V Trueb, U C Dubach, R C Heintz, V Ascalone, I Forgo, U Hennes
PMCID: PMC1463716  PMID: 3157397

Abstract

The pharmacokinetics of glibornuride (25 mg i.v.) and the accompanying insulin and glucose responses were characterized in eight human subjects in the presence and absence of steady-state tenoxicam (20 mg p.o./day for 2 weeks). Tenoxicam affected neither the pharmacokinetic parameters of glibornuride (systemic clearance, volume of distribution and biological half-life) nor the responses of plasma insulin and blood glucose to glibornuride. The single i.v. dose of glibornuride had no detectable effect on the kinetics of tenoxicam.

Full text

PDF
249

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams W. J., Krueger D. S. Specific and sensitive high-performance liquid chromatographic determination of glyburide. J Pharm Sci. 1979 Sep;68(9):1138–1140. doi: 10.1002/jps.2600680921. [DOI] [PubMed] [Google Scholar]
  2. Benet L. Z., Galeazzi R. L. Noncompartmental determination of the steady-state volume of distribution. J Pharm Sci. 1979 Aug;68(8):1071–1074. doi: 10.1002/jps.2600680845. [DOI] [PubMed] [Google Scholar]
  3. Hansen J. M., Christensen L. K. Drug interactions with oral sulphonylurea hypoglycaemic drugs. Drugs. 1977 Jan;13(1):24–34. doi: 10.2165/00003495-197713010-00003. [DOI] [PubMed] [Google Scholar]
  4. Morrison P. J., Rogers H. J., Spector R. G., Bradbrook I. D., John V. A. Effect of pirprofen on glibenclamide kinetics and response. Br J Clin Pharmacol. 1982 Jul;14(1):123–126. doi: 10.1111/j.1365-2125.1982.tb04949.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Pickup M. E., Lowe J. R., Galloway D. B. Determination of Ro12-0068, a new anti-inflammatory and analgesic compound, in plasma by means of high-performance liquid chromatography. J Chromatogr. 1981 Oct 9;225(2):493–497. doi: 10.1016/s0378-4347(00)80302-3. [DOI] [PubMed] [Google Scholar]
  6. Rentsch G., Schmidt H. A., Rieder J. Zur Pharmakokinetik von Glibornurid. Arzneimittelforschung. 1972 Dec;22(Suppl):2209–2209. [PubMed] [Google Scholar]
  7. Scholer A., Günther M., Wacker M., Persenico J. Glucosebestimmung im Hämolysat, Handanalyse. Schweiz Med Wochenschr. 1980 Mar 29;110(13):491–495. [PubMed] [Google Scholar]
  8. Scholer A., Pianezzi A. Mikromethode zur Bestimmung der Glucosekonzentration mit Glucose-Dehydrogenase auf dem AutoAnalyzer. J Clin Chem Clin Biochem. 1976 Apr;14(4):189–195. [PubMed] [Google Scholar]
  9. Tanaka Y., Maeda M., Nakamura K. [Pharmacologic studies on Ro 12-0068, a new non-steroidal anti-inflammatory drug (author's transl)]. Nihon Yakurigaku Zasshi. 1981 May;77(5):531–552. [PubMed] [Google Scholar]
  10. Tozer T. N. Concepts basic to pharmacokinetics. Pharmacol Ther. 1981;12(1):109–131. doi: 10.1016/0163-7258(81)90077-2. [DOI] [PubMed] [Google Scholar]
  11. Verbeeck R. K., Blackburn J. L., Loewen G. R. Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs. Clin Pharmacokinet. 1983 Jul-Aug;8(4):297–331. doi: 10.2165/00003088-198308040-00003. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES